• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小脑高级别胶质瘤不存在与幕上高级别胶质瘤相同的分子改变,且可能显示组蛋白H3基因突变。

Cerebellar high-grade gliomas do not present the same molecular alterations as supratentorial high-grade gliomas and may show histone H3 gene mutations.

作者信息

Tauziède-Espariat Arnault, Saffroy Raphaël, Pagès Mélanie, Pallud Johan, Legrand Laurence, Besnard Aurore, Lacombe Joëlle, Lot Guillaume, Borha Alin, Tazi Sanaa, Adle-Biassette Homa, Polivka Marc, Lechapt Emmanuèle, Varlet Pascale

出版信息

Clin Neuropathol. 2018 Sep/Oct;37(5):209-216. doi: 10.5414/NP301104.

DOI:10.5414/NP301104
PMID:29809131
Abstract

Numerous molecular alterations have been described in supratentorial high-grade gliomas (1p19q co-deletion, IDH1/2, histone H3, hTERT promotor mutations, loss of ATRX) which have led to a new histomolecular classification of diffuse gliomas. We aimed at describing these alterations in a series of 19 adults with pure cerebellar high-grade gliomas. Systematic immunohistochemical analyses, including that of IDH1R132H, ATRX, p53, PTEN, EGFR, p16, FGFR3, BRAFV600E, mismatch repair proteins, H3K27me3, H3K36me3, and H3K27M; molecular analyses of IDH1/2, hTERT, BRAF, H3F3A, and HIST1H3B mutation hotspots; and EGFR, PTEN FISH were retrospectively performed in a multicentric study. We histopathologically identified 14 glioblastomas, 4 grade III astrocytomas and 1 gliosarcoma. Two cases showed a H3F3A K27M mutation. Only one case harbored a classical profile of glioblastoma with hTERT mutation, EGFR gain and 10q loss. The most frequent alteration was the absence of p16 immunoexpression. We report a histomolecular analysis of pure cerebellar high grade gliomas. The histomolecular profile appears to be different from that of supratentorial gliomas, with no IDH1/2 gene mutations and only 1 case with a classic profile of de novo glioblastoma. In 2 cases, we identified H3F3A K27M mutation, classically described in pediatric midline gliomas.
.

摘要

幕上高级别胶质瘤中已描述了众多分子改变(1p19q 共缺失、异柠檬酸脱氢酶 1/2(IDH1/2)、组蛋白 H3、端粒酶逆转录酶(hTERT)启动子突变、α地中海贫血/智力发育迟缓综合征 X 连锁基因(ATRX)缺失),这些改变促成了弥漫性胶质瘤的新组织分子分类。我们旨在描述 19 例纯小脑高级别胶质瘤成年患者的这些改变。在一项多中心研究中,回顾性地进行了系统免疫组化分析,包括对 IDH1R132H、ATRX、p53、磷酸酶和张力蛋白同源物(PTEN)、表皮生长因子受体(EGFR)、p16、成纤维细胞生长因子受体 3(FGFR3)、BRAF 基因 V600E 突变、错配修复蛋白、组蛋白 H3 赖氨酸 27 三甲基化(H3K27me3)、组蛋白 H3 赖氨酸 36 三甲基化(H3K36me3)和组蛋白 H3 赖氨酸 27 单甲基化(H3K27M)的分析;对 IDH1/2、hTERT、BRAF、组蛋白 H3 家族成员 3A(H3F3A)和 HIST1H3B 突变热点的分子分析;以及 EGFR、PTEN 荧光原位杂交(FISH)。我们通过组织病理学鉴定出 14 例胶质母细胞瘤、4 例三级星形细胞瘤和 1 例胶质肉瘤。2 例显示 H3F3A K27M 突变。仅 1 例具有胶质母细胞瘤的典型特征,伴有 hTERT 突变、EGFR 扩增和 10q 缺失。最常见的改变是 p16 免疫表达缺失。我们报告了纯小脑高级别胶质瘤的组织分子分析。其组织分子特征似乎与幕上胶质瘤不同,无 IDH1/2 基因突变,仅有 1 例具有新发胶质母细胞瘤的典型特征。在 2 例中,我们鉴定出 H3F3A K27M 突变,这在儿童中线胶质瘤中经典描述。

相似文献

1
Cerebellar high-grade gliomas do not present the same molecular alterations as supratentorial high-grade gliomas and may show histone H3 gene mutations.小脑高级别胶质瘤不存在与幕上高级别胶质瘤相同的分子改变,且可能显示组蛋白H3基因突变。
Clin Neuropathol. 2018 Sep/Oct;37(5):209-216. doi: 10.5414/NP301104.
2
Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations.伴组蛋白H3-K27M突变的弥漫性中线胶质瘤:47例病例系列研究,评估形态学变异谱及相关基因改变
Brain Pathol. 2016 Sep;26(5):569-80. doi: 10.1111/bpa.12336. Epub 2015 Dec 14.
3
Molecular analysis of diffuse intrinsic brainstem gliomas in adults.成人弥漫性脑桥内生型胶质瘤的分子分析
J Neurooncol. 2014 Jan;116(2):405-11. doi: 10.1007/s11060-013-1312-2. Epub 2013 Nov 17.
4
A case report of adult cerebellar high-grade glioma with H3.1 K27M mutation: a rare example of an H3 K27M mutant cerebellar tumor.成人小脑高级别胶质瘤伴 H3.1 K27M 突变病例报告:H3 K27M 突变小脑肿瘤的罕见病例。
Brain Tumor Pathol. 2018 Jan;35(1):29-35. doi: 10.1007/s10014-017-0305-9. Epub 2017 Dec 20.
5
H3F3A K27M mutations in thalamic gliomas from young adult patients.丘脑胶质瘤中年轻成年患者的 H3F3A K27M 突变。
Neuro Oncol. 2014 Jan;16(1):140-6. doi: 10.1093/neuonc/not144. Epub 2013 Nov 26.
6
Significance of H3K27M mutation with specific histomorphological features and associated molecular alterations in pediatric high-grade glial tumors.H3K27M突变在小儿高级别胶质瘤中具有特定组织形态学特征及相关分子改变的意义。
Childs Nerv Syst. 2018 Jan;34(1):107-116. doi: 10.1007/s00381-017-3633-5. Epub 2017 Oct 24.
7
Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas.影像学诊断的中线胶质瘤中 H3 K27M 突变的发生率及临床病理特征。
J Neurooncol. 2019 May;143(1):87-93. doi: 10.1007/s11060-019-03134-x. Epub 2019 Mar 12.
8
Histone H3 K27M mutations in adult cerebellar high-grade gliomas.成人小脑高级别胶质瘤中的组蛋白H3 K27M突变
Brain Tumor Pathol. 2017 Jul;34(3):113-119. doi: 10.1007/s10014-017-0288-6. Epub 2017 May 25.
9
Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics.成人弥漫性中线胶质瘤:临床、影像学和遗传学特征。
J Clin Neurosci. 2020 Dec;82(Pt A):1-8. doi: 10.1016/j.jocn.2020.10.005. Epub 2020 Nov 1.
10
H3 K27M-mutant diffuse midline gliomas in different anatomical locations.不同解剖部位 H3 K27M 突变型弥漫中线胶质瘤。
Hum Pathol. 2018 Aug;78:89-96. doi: 10.1016/j.humpath.2018.04.015. Epub 2018 May 1.

引用本文的文献

1
ATRX loss in adult gliomas lacking H3 alterations or IDH mutations, an exceptional situation for exceptional diagnoses: the experience of Sainte-Anne hospital.在缺乏H3改变或异柠檬酸脱氢酶(IDH)突变的成人胶质瘤中ATRX缺失:特殊诊断的特殊情况——圣安妮医院的经验
Acta Neuropathol Commun. 2025 Jun 13;13(1):131. doi: 10.1186/s40478-025-02044-6.
2
Investigating distinct clinical features and constructing a nomogram model for survival probability in adults with cerebellar high-grade gliomas.探讨成人小脑高级别胶质瘤的独特临床特征并构建生存概率列线图模型。
BMC Cancer. 2024 Jul 13;24(1):836. doi: 10.1186/s12885-024-12580-4.
3
Primary Intracranial Gliosarcoma: Is It Really a Variant of Glioblastoma? An Update of the Clinical, Radiological, and Biomolecular Characteristics.
原发性颅内胶质肉瘤:它真的是胶质母细胞瘤的一种变体吗?临床、放射学及生物分子特征的最新进展
J Clin Med. 2023 Dec 22;13(1):83. doi: 10.3390/jcm13010083.
4
Rapid Brainstem Infiltration of a Cerebellar Glioblastoma.小脑胶质母细胞瘤的快速脑干浸润
Cureus. 2022 Feb 27;14(2):e22643. doi: 10.7759/cureus.22643. eCollection 2022 Feb.
5
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
6
Discernable differences in the genetic and molecular profile of cerebellar glioblastoma.小脑胶质母细胞瘤在基因和分子特征方面存在可辨别的差异。
Transl Cancer Res. 2019 Dec;8(Suppl 6):S553-S558. doi: 10.21037/tcr.2019.08.24.
7
Diffuse midline glioma with H3 K27M-mutation in an 83-year-old woman.一名 83 岁女性患有弥漫性中线胶质瘤,伴有 H3 K27M 突变。
CNS Oncol. 2021 Jun 1;10(2):CNS71. doi: 10.2217/cns-2020-0030. Epub 2021 Apr 28.
8
Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma.法国多中心 118 例成人小脑胶质母细胞瘤患者的管理、功能结局和生存分析。
J Cancer Res Clin Oncol. 2021 Jun;147(6):1843-1856. doi: 10.1007/s00432-020-03474-6. Epub 2021 Jan 5.
9
Treatment patterns and outcomes for cerebellar glioblastoma in the concomitant chemoradiation era: A National Cancer database study.同期放化疗时代小脑胶质母细胞瘤的治疗模式和结局:一项国家癌症数据库研究。
J Clin Neurosci. 2020 Dec;82(Pt A):122-127. doi: 10.1016/j.jocn.2020.10.049. Epub 2020 Nov 6.
10
Primary cerebellar glioblastomas in children: clinical presentation and management.儿童小脑原发性胶质母细胞瘤:临床表现与治疗。
Neurosurg Rev. 2021 Jun;44(3):1747-1754. doi: 10.1007/s10143-020-01373-5. Epub 2020 Aug 26.